UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review

European journal of medicinal chemistry, 2020-11, Vol.206, p.112787-112787, Article 112787

2020

Volltextzugriff (PDF)

New Frontiers in Selective Human MAO-B Inhibitors

Journal of medicinal chemistry, 2015-09, Vol.58 (17), p.6717-6732

2015

Volltextzugriff (PDF)

Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs

Molecules (Basel, Switzerland), 2017-07, Vol.22 (7), p.1192

2017

Volltextzugriff (PDF)

Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy

Nature communications, 2021-06, Vol.12 (1), p.3530-17, Article 3530

2021

Volltextzugriff (PDF)

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors

European journal of medicinal chemistry, 2020-11, Vol.205, p.112650-112650, Article 112650

2020

Volltextzugriff (PDF)

Monoamine Oxidase B Inhibitors in Parkinson's Disease

CNS & neurological disorders drug targets, 2017-01, Vol.16 (4), p.425

2017

Volltextzugriff (PDF)

Structure-Based Design and Optimization of Multitarget-Directed 2H‑Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases

Journal of medicinal chemistry, 2015-07, Vol.58 (14), p.5561

2015

Volltextzugriff (PDF)

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors

Molecules (Basel, Switzerland), 2020-05, Vol.25 (10), p.2356

2020

Volltextzugriff (PDF)

GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease

Nature medicine, 2014-08, Vol.20 (8), p.886-896

2014

Volltextzugriff (PDF)

Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation

European journal of medicinal chemistry, 2016-10, Vol.121, p.864-879

2016

Volltextzugriff (PDF)

Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases

Archiv der Pharmazie (Weinheim), 2019-11, Vol.352 (11), p.e1900177-n/a

2019

Volltextzugriff (PDF)

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

European journal of medicinal chemistry, 2014-06, Vol.80, p.543-561

2014

Volltextzugriff (PDF)

MAO inhibitors and their wider applications: a patent review

Expert opinion on therapeutic patents, 2018-03, Vol.28 (3), p.211-226

2018

Volltextzugriff (PDF)

Synthesis, Structural Reassignment, and Biological Activity of Type B MAO Inhibitors Based on the 5H-Indeno[1,2-c]pyridazin-5-one Core

Journal of medicinal chemistry, 2006-06, Vol.49 (12), p.3743-3747

2006

Volltextzugriff (PDF)

Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?

Journal of medicinal chemistry, 2017-08, Vol.60 (16), p.7206-7212

2017

Volltextzugriff (PDF)

Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors

European journal of medicinal chemistry, 2022-02, Vol.229, p.114097-114097, Article 114097

2022

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease

European journal of medicinal chemistry, 2017-10, Vol.139, p.48-59

2017

Volltextzugriff (PDF)

Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors

Journal of medicinal chemistry, 2016-06, Vol.59 (12), p.5879-5893

2016

Volltextzugriff (PDF)

Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation

Bioorganic chemistry, 2018-12, Vol.81, p.512-528

2018

Volltextzugriff (PDF)

Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors

European journal of medicinal chemistry, 2016-05, Vol.114, p.162-169

2016

Volltextzugriff (PDF)

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future

Journal of Parkinson's disease, 2022-01, Vol.12 (2), p.477-493

2022

Volltextzugriff (PDF)

Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease

European journal of medicinal chemistry, 2018-01, Vol.143, p.33-47

2018

Volltextzugriff (PDF)

Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease

European journal of medicinal chemistry, 2019-10, Vol.180, p.367-382

2019

Volltextzugriff (PDF)

A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer’s disease

Bioorganic & medicinal chemistry, 2013-05, Vol.21 (9), p.2434-2450

2013

Volltextzugriff (PDF)

Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors

Journal of biomolecular structure & dynamics, 2023-04, Vol.41 (6), p.2326-2340

2023

Volltextzugriff (PDF)

1 – 25 von 7.899

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(6.582)
Mit Volltextzugriff
(5.197)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

15 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

Science & Technology
(5.727)
Life Sciences & Biomedicine
(5.584)
Animals
(5.033)
Monoamine Oxidase Inhibitors - Pharmacology
(4.886)
Pharmacology & Pharmacy
(3.332)
Humans
(3.292)
Male
(3.105)
Rats
(2.971)
Biological And Medical Sciences
(2.209)
Monoamine Oxidase - Metabolism
(2.129)
Medical Sciences
(1.826)
Pharmacology. Drug Treatments
(1.580)
Neurosciences & Neurology
(1.451)
Female
(1.331)
Neurosciences
(1.292)
Monoamine Oxidase Inhibitors
(1.168)
Neuropharmacology
(1.129)
Mice
(1.104)
Monoamine Oxidase
(997)
Monoamine Oxidase Inhibitors - Therapeutic Use
(989)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(11)

Menü

Weitere Dienste

Einstellungen

A comprehensive review of monoamine oxidase inhibitors as Anti-Alzheimer’s disease agents: A review

New Frontiers in Selective Human MAO-B Inhibitors

Assessment of Enzyme Inhibition: A Review with Examples from the Development of Monoamine Oxidase and Cholinesterase Inhibitory Drugs

Targeting monoamine oxidase A-regulated tumor-associated macrophage polarization for cancer immunotherapy

Chalcones: Unearthing their therapeutic possibility as monoamine oxidase B inhibitors

Monoamine Oxidase B Inhibitors in Parkinson's Disease

Structure-Based Design and Optimization of Multitarget-Directed 2H‑Chromen-2-one Derivatives as Potent Inhibitors of Monoamine Oxidase B and Cholinesterases

Novel Class of Chalcone Oxime Ethers as Potent Monoamine Oxidase-B and Acetylcholinesterase Inhibitors

GABA from reactive astrocytes impairs memory in mouse models of Alzheimer's disease

Donepezil-like multifunctional agents: Design, synthesis, molecular modeling and biological evaluation

Emerging therapeutic potentials of dual‐acting MAO and AChE inhibitors in Alzheimer's and Parkinson's diseases

Donepezil + propargylamine + 8-hydroxyquinoline hybrids as new multifunctional metal-chelators, ChE and MAO inhibitors for the potential treatment of Alzheimer's disease

MAO inhibitors and their wider applications: a patent review

Synthesis, Structural Reassignment, and Biological Activity of Type B MAO Inhibitors Based on the 5H-Indeno[1,2-c]pyridazin-5-one Core

Coumarin versus Chromone Monoamine Oxidase B Inhibitors: Quo Vadis?

Synthesis of novel thiazolyl hydrazone derivatives as potent dual monoamine oxidase-aromatase inhibitors

Design, synthesis and biological evaluation of novel coumarin-N-benzyl pyridinium hybrids as multi-target agents for the treatment of Alzheimer's disease

Discovery of New Chemical Entities for Old Targets: Insights on the Lead Optimization of Chromone-Based Monoamine Oxidase B (MAO-B) Inhibitors

Coumarin-dithiocarbamate hybrids as novel multitarget AChE and MAO-B inhibitors against Alzheimer’s disease: Design, synthesis and biological evaluation

Design and synthesis of novel chalcones as potent selective monoamine oxidase-B inhibitors

Monoamine Oxidase-B Inhibitors for the Treatment of Parkinson's Disease: Past, Present, and Future

Discovery of novel propargylamine-modified 4-aminoalkyl imidazole substituted pyrimidinylthiourea derivatives as multifunctional agents for the treatment of Alzheimer's disease

Design, synthesis and biological evaluation of hydroxypyridinone-coumarin hybrids as multimodal monoamine oxidase B inhibitors and iron chelates against Alzheimer's disease

A comprehensive review on synthesis and designing aspects of coumarin derivatives as monoamine oxidase inhibitors for depression and Alzheimer’s disease

Structural exploration of selected C6 and C7-substituted coumarin isomers as selective MAO-B inhibitors

Suchergebnisse filtern